Jan. 6, 2023 — The highly anticipated Alzheimer’s drug lecanemab was granted accelerated approval status this afternoon by the FDA, offering hope where there has been little for patients and their families affected by the devastating disease.More than 6 million people in the U.S. live with…
Source: www.webmd.com – Read more

Stolen Credentials and Valid Account Abuse Fuel the Financially Motivated Attacks
Throughout the first half of 2025, financially motivated threat actors have shifted their approach to intrusions, abandoning traditional implant-heavy methods in favor of a more
 
															

